Gene: EFCAB14
Official Full Name: EF-hand calcium binding domain 14provided by HGNC
Gene Summary: Predicted to enable calcium ion binding activity. Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO32725 | EFCAB14 Knockout cell line (HeLa) | Human | EFCAB14 | 1:3~1:6 | Negative | Online Inquiry |
KO32726 | EFCAB14 Knockout cell line (HCT 116) | Human | EFCAB14 | 1:2~1:4 | Negative | Online Inquiry |
KO32727 | EFCAB14 Knockout cell line (HEK293) | Human | EFCAB14 | 1:3~1:6 | Negative | Online Inquiry |
KO32728 | EFCAB14 Knockout cell line (A549) | Human | EFCAB14 | 1:3~1:4 | Negative | Online Inquiry |
EFCAB14 Gene Knockout Cell Lines offer a cutting-edge tool for researchers focused on understanding the functional roles of the EFCAB14 gene in cellular processes. EFCAB14 (EF-hand calcium-binding protein 14) is implicated in various signaling pathways and cellular functions, making its study crucial for deciphering both normal physiology and pathological conditions. These gene knockout cell lines utilize advanced CRISPR-Cas9 technology to create precise disruptions in the EFCAB14 gene, resulting in a cell line that provides clearer insights into the gene's specific contributions.
The primary function of the EFCAB14 knockout cell lines is to facilitate the analysis of gene function, cellular interactions, and downstream effects of EFCAB14 loss-of-function. By enabling researchers to observe phenotypic changes in these cell lines, they can study aspects such as calcium signaling, cell proliferation, and differentiation with greater accuracy. Furthermore, the ability to use these knockout lines in combination with other molecular techniques, such as transcriptomic and proteomic analyses, amplifies their utility in a variety of experimental settings.
The scientific importance of EFCAB14 gene knockout cell lines cannot be overstated as they provide a mechanism to model diseases linked to calcium signaling dysregulation, including certain cancers and neurodegenerative diseases. In clinical research, these models can accelerate the discovery of therapeutic targets and drug candidates, thus holding potential for translational applications.
What sets EFCAB14 gene knockout cell lines apart from other genetic models is their precision, ease of use, and reproducibility. The CRISPR-Cas9 technology allows for efficient knockout generation with minimal off-target effects, ensuring that the observed results are directly linked to the loss of EFCAB14 function. Additionally, these cell lines are readily available for purchase, thereby reducing the lead time for researchers initiating experimental work.
For researchers and clinicians dedicated to unraveling the complexities of gene and protein interactions, EFCAB14 gene knockout cell lines represent a valuable asset that can provide in-depth knowledge and pave the way for future innovations. With a company dedicated to delivering high-quality biological products and a strong foundation in genetic research, we are committed to providing our customers with precise and reliable tools that advance scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.